This bill ensures continued funding for Maine's children's residential care facilities by making newly appropriated funds nonlapsing - meaning unspent money carries over to future fiscal years instead of expiring. It directly affects facilities that provide residential care for children and receive reimbursement through MaineCare (the state's Medicaid program), which face potential bed reductions or closures due to funding gaps. The bill removes a requirement for an emergency rate adjustment process for these facilities, streamlining how they receive funding. Key provisions focus on stabilizing financial support to maintain access to critical care services for vulnerable children.
This bill requires the Maine Department of Health and Human Services to amend its rules so that hospitals participating in MaineCare receive at least 75% of the amount they report for costs within 90 days of submitting their cost reports. It directly affects hospitals that submit cost reports for reimbursement under MaineCare, the state's Medicaid program. The change mandates this timeline and reimbursement rate through updates to the MaineCare Benefits Manual (Chapter 101, Chapter III, Section 45) and must be implemented using existing department resources without new state funding.
LD 182 requires Maine's Department of Health and Human Services to set MaineCare reimbursement rates for Maine Veterans' Homes on a per-resident daily basis. This directly affects veterans' facilities (including nursing homes and residential care facilities operated by Maine Veterans' Homes) and ensures MaineCare covers the portion of their operating costs tied to residents receiving MaineCare benefits. The bill mandates annual inflation adjustments to these rates and allows the department to use data from other states or hire third parties to establish them. It does not change eligibility but standardizes how costs for covered residents are calculated and reimbursed.
This bill requires health insurance plans in Maine to cover blood testing for perfluoroalkyl and polyfluoroalkyl substances (PFAS) when a healthcare provider deems it medically necessary based on guidelines from the National Academies of Sciences, Engineering, and Medicine. It prohibits insurers from charging deductibles, copays, or coinsurance for these tests. The requirement applies to all health insurance plans issued or renewed in Maine on or after January 1, 2026. The bill states this coverage does not expand the state's essential health benefits under federal law, as it aligns with existing coverage for outpatient lab services.
This resolve authorizes the final adoption of specific regulatory provisions concerning the prescriptive authorities and collaborative relationships for naturopathic doctors in Maine. The Department of Professional and Financial Regulation submitted these rules to the legislature after the standard filing deadline, which required a special legislative action to approve them. By passing this measure, the state legislature grants the necessary approval for these professional practice standards to take effect immediately.
This bill expands vaccine access in Maine by allowing licensed pharmacists to prescribe, dispense, and administer FDA-approved vaccines without requiring a doctor's prescription for eligible patients. It requires health insurance plans and the MaineCare program to cover all vaccines without deductibles, copayments, or other out-of-pocket costs, including coverage for off-label vaccine use. Pharmacists can administer influenza vaccines to people aged 3 and older, and other CDC-recommended vaccines to adults 18 and older, with additional authority for COVID-19 vaccines to those aged 3 and older. The legislation also clarifies legal definitions for off-label use and medically accepted indications to support these expanded prescribing and administration powers.
This bill amends Maine's optometry practice laws to clarify the scope of services optometrists can provide. It explicitly permits optometrists to prescribe hydrocodone combination products and other controlled substances (such as schedule III-V drugs) for eye conditions, while listing specific procedures excluded from optometry practice (e.g., corneal transplants, retinal surgery, and surgeries requiring general anesthesia). The bill also requires optometrists to meet board-established credentialing standards before performing any ophthalmic surgery or laser procedures. These changes directly affect Maine optometrists by defining their prescribing authority and procedural boundaries.
This Maine bill requires hospitals to submit a formal notice to the state department at least 120 days before closing labor and delivery units or changing the level of maternity and newborn care services. The notification must include the effective date, reasons for the change, contact information, and details on how the hospital will handle emergency obstetric care. Hospitals must also document their efforts to notify surrounding facilities within 50 miles, local emergency services, affected patients, and the general public. These provisions are designed to ensure transparency and allow communities adequate time to prepare for changes in essential healthcare services.
This bill allows physician associates to work as the main healthcare providers in clinics that do not have a doctor on staff, removing the current requirement for them to have a formal practice agreement with an active physician. It also changes consultation rules by making it optional for physician associates to consult with physicians and removes the mandate that a physician must be available at all times for consultation. These changes aim to address shortages of medical providers, particularly in rural areas, by increasing the number of physician associates who can practice primary care. The legislation applies to physician associates, healthcare facilities, and medical practices across Maine.
This bill amends Maine's insurance code to explicitly include the MaineCare program as a "carrier" for prescription drug benefit purposes. The change clarifies that MaineCare, which provides health coverage to low-income residents, is treated similarly to private insurance carriers under state insurance regulations. By adding MaineCare to the definition of carrier, the legislation ensures the program falls under existing insurance code provisions governing prescription drug benefits. This adjustment affects how MaineCare is classified within the state's insurance framework without altering the program's core eligibility or funding structure.
